Lexicon Pharmaceuticals Ownership 2024 | Who Owns Lexicon Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

69.35%

Insider Ownership

1.15%

Retail Ownership

29.51%

Institutional Holders

65.00

Lexicon Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.53.16%7.19%117,553,284--282,127,882Mar 31, 2024
FMR LLC6.28%0.00%13,894,06211,617,594510.33%33,345,749Mar 31, 2024
BLACKROCK INC.3.48%0.00%7,693,277688,1249.82%18,463,864Mar 31, 2024
VANGUARD GROUP INC2.89%0.00%6,401,225420,8547.04%15,362,940Mar 31, 2024
ORBIMED ADVISORS LLC1.60%0.16%3,542,0003,542,000100.00%8,500,800Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.08%0.00%2,389,13740,2211.71%5,734,687Mar 31, 2024
NEA MANAGEMENT COMPANY, LLC1.08%0.35%2,382,286--5,717,486Mar 31, 2024
STATE STREET CORP0.90%0.00%1,987,51095,1915.03%4,770,024Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.89%0.00%1,972,2001,972,200100.00%4,733,280Mar 31, 2024
PINNACLE ASSOCIATES LTD0.79%0.07%1,747,83017,0090.98%4,194,792Mar 31, 2024
BVF INC/IL0.76%0.11%1,686,924-22,748,708-93.10%4,048,618Mar 31, 2024
AMERIPRISE FINANCIAL INC0.64%0.00%1,417,950-472,250-24.98%3,403,080Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.64%0.02%1,404,9281,404,928100.00%3,371,827Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.43%0.04%960,150960,150100.00%5,348,625Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.40%0.00%881,12316,9481.96%2,114,695Mar 31, 2024
NORTHERN TRUST CORP0.39%0.00%866,5566,9680.81%2,079,735Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.31%0.00%686,418686,418100.00%1,647,403Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.26%0.00%584,386584,386100.00%1,402,526Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.24%0.00%534,184-1,098,992-67.29%1,282,042Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.24%0.00%524,177113,13127.52%1,258,025Mar 31, 2024

Lexicon Pharmaceuticals's largest institutional shareholder is ARTAL GROUP S.A., holding 53.16% of the company's total share outstanding, currently valued at $282.13M. The top 10 institutional shareholders own together 72.16% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.53.16%7.19%117,553,284--282,127,882Mar 31, 2024
VIRTUS ETF ADVISERS LLC0.13%0.37%293,09242,16916.81%703,421Mar 31, 2024
NEA MANAGEMENT COMPANY, LLC1.08%0.35%2,382,286--5,717,486Mar 31, 2024
BOULDER HILL CAPITAL MANAGEMENT LP0.12%0.25%256,400256,400100.00%615,360Mar 31, 2024
ORBIMED ADVISORS LLC1.60%0.16%3,542,0003,542,000100.00%8,500,800Mar 31, 2024
BVF INC/IL0.76%0.11%1,686,924-22,748,708-93.10%4,048,618Mar 31, 2024
PINNACLE ASSOCIATES LTD0.79%0.07%1,747,83017,0090.98%4,194,792Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.13%0.06%293,333-486,744-62.40%704,000Mar 31, 2024
PROSPERITY FINANCIAL GROUP, INC.0.01%0.05%31,500--75,600Mar 31, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO0.02%0.04%35,714--86,000Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.43%0.04%960,150960,150100.00%5,348,625Mar 31, 2024
VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC0.01%0.02%12,41512,415100.00%29,796Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.64%0.02%1,404,9281,404,928100.00%3,371,827Mar 31, 2024
LIFESTEPS FINANCIAL, INC.0.00%0.02%10,000--24,000Mar 31, 2024
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD.0.02%0.01%46,93018,60165.66%113,000Mar 31, 2024
KWB WEALTH0.02%0.01%40,640--97,536Mar 31, 2024
COYLE FINANCIAL COUNSEL LLC0.01%0.01%12,50012,500100.00%30,000Mar 31, 2024
CHEMISTRY WEALTH MANAGEMENT LLC0.01%0.01%12,000--28,800Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.14%0.01%319,058319,058100.00%766,000Mar 31, 2024
BBR PARTNERS, LLC0.01%0.01%30,00030,000100.00%72,000Mar 31, 2024

The largest Lexicon Pharmaceuticals shareholder by % of total assets is ARTAL GROUP S.A.. The company owns 117.55M shares of Lexicon Pharmaceuticals (LXRX), representing 7.19% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC6.28%0.00%13,894,06211,617,594510.33%33,345,749Mar 31, 2024
ORBIMED ADVISORS LLC1.60%0.16%3,542,0003,542,000100.00%8,500,800Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.89%0.00%1,972,2001,972,200100.00%4,733,280Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.64%0.02%1,404,9281,404,928100.00%3,371,827Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.43%0.04%960,150960,150100.00%5,348,625Mar 31, 2024
BLACKROCK INC.3.48%0.00%7,693,277688,1249.82%18,463,864Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.31%0.00%686,418686,418100.00%1,647,403Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.26%0.00%584,386584,386100.00%1,402,526Mar 31, 2024
MARSHALL WACE, LLP0.23%0.00%499,172499,172100.00%1,198,014Mar 31, 2024
VANGUARD GROUP INC2.89%0.00%6,401,225420,8547.04%15,362,940Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.14%0.01%319,058319,058100.00%766,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.13%0.00%290,900290,900100.00%698,160Mar 31, 2024
BOULDER HILL CAPITAL MANAGEMENT LP0.12%0.25%256,400256,400100.00%615,360Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.24%0.00%524,177113,13127.52%1,258,025Mar 31, 2024
CITADEL ADVISORS LLC0.06%0.00%136,20097,800254.69%326,880Mar 31, 2024
STATE STREET CORP0.90%0.00%1,987,51095,1915.03%4,770,024Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.04%0.00%95,18495,184100.00%228,000Mar 31, 2024
NATIXIS ADVISORS, L.P.0.04%0.00%86,09486,094100.00%207,000Mar 31, 2024
LAZARD FRERES GESTION S.A.S.0.02%0.00%50,00050,000100.00%119,000Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.02%-49,94349,943100.00%119,863Mar 31, 2024

As of Mar 31 2024, Lexicon Pharmaceuticals's largest institutional buyer is FMR LLC. The company purchased 11.62M stocks of LXRX, valued at $33.35M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL0.76%0.11%1,686,924-22,748,708-93.10%4,048,618Mar 31, 2024
JPMORGAN CHASE & CO0.04%-90,136-2,953,155-97.04%216,326Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.24%0.00%534,184-1,098,992-67.29%1,282,042Mar 31, 2024
MORGAN STANLEY0.11%-244,209-673,479-73.39%586,101Mar 31, 2024
CITADEL ADVISORS LLC0.06%0.00%134,477-651,683-82.89%322,745Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.13%0.06%293,333-486,744-62.40%704,000Mar 31, 2024
AMERIPRISE FINANCIAL INC0.64%0.00%1,417,950-472,250-24.98%3,403,080Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----412,175-100.00%-Mar 31, 2024
D. E. SHAW & CO., INC.----359,210-100.00%-Mar 31, 2024
ENTRYPOINT CAPITAL, LLC----323,968-100.00%-Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----282,467-100.00%-Mar 31, 2024
CITIGROUP INC0.01%-17,548-207,450-92.20%42,115Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC--10-150,090-99.99%23,000Mar 31, 2024
BANK OF AMERICA CORP /DE/0.04%-85,872-124,853-59.25%206,092,000Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----103,144-100.00%-Mar 31, 2024
GOLDMAN SACHS GROUP INC0.07%0.00%156,214-79,125-33.62%374,914Mar 31, 2024
BARCLAYS PLC0.03%0.00%64,619-62,397-49.13%155,000Mar 31, 2024
AMUNDI----54,532-100.00%-Mar 31, 2024
SIMPLEX TRADING, LLC----54,248-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP0.13%0.00%292,006-49,071-14.39%700,815Mar 31, 2024

As of Mar 31 2024, Lexicon Pharmaceuticals's biggest institutional seller is BVF INC/IL. The company sold -22.75M shares of LXRX, valued at $4.05M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ORBIMED ADVISORS LLC1.60%0.16%3,542,0003,542,000100.00%8,500,800Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.89%0.00%1,972,2001,972,200100.00%4,733,280Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.64%0.02%1,404,9281,404,928100.00%3,371,827Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.26%0.00%584,386584,386100.00%1,402,526Mar 31, 2024
MARSHALL WACE, LLP0.23%0.00%499,172499,172100.00%1,198,014Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.14%0.01%319,058319,058100.00%766,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.13%0.00%290,900290,900100.00%698,160Mar 31, 2024
BOULDER HILL CAPITAL MANAGEMENT LP0.12%0.25%256,400256,400100.00%615,360Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.04%0.00%95,18495,184100.00%228,000Mar 31, 2024
NATIXIS ADVISORS, L.P.0.04%0.00%86,09486,094100.00%207,000Mar 31, 2024
LAZARD FRERES GESTION S.A.S.0.02%0.00%50,00050,000100.00%119,000Mar 31, 2024
WEDBUSH SECURITIES INC0.02%0.00%41,65041,650100.00%100,000Mar 31, 2024
BANK OF MONTREAL /CAN/0.02%-40,00140,001100.00%87,602Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.02%0.00%34,43334,433100.00%82,639Mar 31, 2024
BBR PARTNERS, LLC0.01%0.01%30,00030,000100.00%72,000Mar 31, 2024
CERITY PARTNERS LLC0.01%0.00%22,51222,512100.00%54,028Mar 31, 2024
HRT FINANCIAL LP0.01%0.00%16,96516,965100.00%40,000Mar 31, 2024
KESTRA ADVISORY SERVICES, LLC0.01%0.00%14,50014,500100.00%34,800Mar 31, 2024
NORTH STAR ASSET MANAGEMENT INC0.01%0.00%12,55012,550100.00%30,120Mar 31, 2024
COYLE FINANCIAL COUNSEL LLC0.01%0.01%12,50012,500100.00%30,000Mar 31, 2024
VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC0.01%0.02%12,41512,415100.00%29,796Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.00%-10,84310,843100.00%26,023Mar 31, 2024
CETERA ADVISORS LLC0.00%0.00%10,67510,675100.00%25,620Mar 31, 2024
RIVER WEALTH ADVISORS LLC0.00%0.00%10,00010,000100.00%24,000Mar 31, 2024
NORDWAND ADVISORS, LLC0.00%0.00%4,0004,000100.00%9,600Mar 31, 2024
US BANCORP \DE\0.00%-1,2001,200100.00%2,880Mar 31, 2024
COMERICA BANK0.00%-122122100.00%293,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--2121100.00%50Mar 31, 2024

Lexicon Pharmaceuticals's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 3.54M shares, valued at $8.50M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----412,175-100.00%-Mar 31, 2024
D. E. SHAW & CO., INC.----359,210-100.00%-Mar 31, 2024
ENTRYPOINT CAPITAL, LLC----323,968-100.00%-Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----282,467-100.00%-Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----103,144-100.00%-Mar 31, 2024
AMUNDI----54,532-100.00%-Mar 31, 2024
SIMPLEX TRADING, LLC----54,248-100.00%-Mar 31, 2024
TUDOR INVESTMENT CORP ET AL----47,101-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----38,268-100.00%-Mar 31, 2024
WOLVERINE TRADING, LLC----33,400-100.00%-Mar 31, 2024
BAYESIAN CAPITAL MANAGEMENT, LP----32,119-100.00%-Mar 31, 2024
RPO LLC----32,000-100.00%-Mar 31, 2024
OPPENHEIMER & CO INC----24,500-100.00%-Mar 31, 2024
CANTOR FITZGERALD, L. P.----16,522-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----16,054-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----14,400-100.00%-Mar 31, 2024
ASSETMARK, INC----10,000-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----242-100.00%-Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC----204-100.00%-Mar 31, 2024
JNBA FINANCIAL ADVISORS----13-100.00%-Mar 31, 2024

Lexicon Pharmaceuticals's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.41M shares, valued at -, as of undefined.

Lexicon Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Federated Hermes MDT Series0.69%1,694,584--Jan 31, 2024
Monteagle Funds0.38%15,600--Feb 29, 2024
ETFis Series Trust I0.17%250,923129,212106.16%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.17%84,532--Dec 31, 2023
Humankind Benefit Corp0.07%1,584--Dec 31, 2023
FORUM FUNDS II0.05%50,162--Jan 31, 2024
BRIDGEWAY FUNDS INC0.05%135,500--Dec 29, 2023
FIDELITY MT VERNON STREET TRUST0.05%1,422,974--Feb 29, 2024
VANGUARD EXPLORER FUND0.04%542,066--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%14,403--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.02%159,542--Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.02%75,766--Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.02%1,087,400--Feb 29, 2024
SSGA FUNDS0.02%7,167--Feb 29, 2024
AMG FUNDS III0.02%2,624--Feb 29, 2024
VANGUARD INDEX FUNDS0.01%6,908,9821,785,82534.86%Dec 31, 2023
Lattice Strategies Trust0.01%25,162--Dec 31, 2023
Fidelity Commonwealth Trust II0.01%79,058--Aug 31, 2023
DELAWARE GROUP EQUITY FUNDS IV0.01%11,697--Dec 29, 2023
TIAA SEPARATE ACCOUNT VA 10.01%1,763--Dec 31, 2023
GPS Funds I0.01%34,436--Dec 31, 2023
JNL VARIABLE FUND LLC0.01%36,367--Mar 31, 2020
FIDELITY CONCORD STREET TRUST0.01%1,228,73574,5786.46%Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%623,86122,1823.69%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%81,719--Dec 31, 2023
Principal Exchange-Traded Funds0.00%31,571--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%45,209--Feb 29, 2024
Calvert Variable Products, Inc.0.00%5,367--Dec 31, 2023
MFS VARIABLE INSURANCE TRUST III0.00%33,448--Dec 31, 2023
VANGUARD HORIZON FUNDS0.00%43,089--Dec 31, 2023
VALIC Co I0.00%528,06839,2548.03%Feb 29, 2024
Federated Hermes Global Allocation Fund0.00%16,015--Feb 29, 2024
JPMORGAN TRUST II0.00%1,465,284--Feb 29, 2024
TIMOTHY PLAN0.00%5,824--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%37,359--Dec 31, 2023
COLUMBIA FUNDS VARIABLE INSURANCE TRUST0.00%491,608170,06852.89%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%4,215--Dec 31, 2023
VANGUARD WORLD FUND0.00%202,626--Feb 29, 2024
SunAmerica Specialty Series0.00%340--Apr 30, 2021
VANGUARD QUANTITATIVE FUNDS0.00%5,400-22,500-80.65%Dec 31, 2023
PFM Multi-Manager Series Trust0.00%500--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%1,227--Dec 31, 2023
RUSSELL INVESTMENT CO0.00%132,690--Jan 31, 2024
HC CAPITAL TRUST0.00%12,224--Dec 31, 2023
EQ ADVISORS TRUST0.00%413,79018,1904.60%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%31,0218,30036.53%Dec 31, 2023
Legg Mason ETF Investment Trust0.00%11,082--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%4,516--Dec 31, 2023
TRUST FOR PROFESSIONAL MANAGERS0.00%70,439--Feb 29, 2024
iSHARES TRUST0.00%3,623,099--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%228,057--Jan 31, 2024
Advisors' Inner Circle Fund II0.00%180,000--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%409,94249,37313.69%Feb 29, 2024
RYDEX SERIES FUNDS0.00%845--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%224,890--Dec 31, 2023
Victory Portfolios II0.00%10,585--Dec 31, 2023
PGIM ETF TRUST0.00%11,691--Feb 29, 2024
WisdomTree Trust0.00%353,947--Feb 29, 2024
ProFunds0.00%1,32054169.45%Jan 31, 2024
RBB FUND, INC.0.00%13,143--Feb 29, 2024
PROSHARES TRUST0.00%31,8734,28115.52%Feb 29, 2024
ALLSPRING MASTER TRUST0.00%8,160--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%37,76613,93658.48%Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%419--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%12,745--Dec 31, 2023
PENN SERIES FUNDS INC0.00%2,560--Dec 29, 2023
Goldman Sachs ETF Trust0.00%8,796--Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%4,768--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%10,276-213-2.03%Jan 31, 2024
RUSSELL INVESTMENT FUNDS0.00%5,000--Dec 31, 2023
ADVANCED SERIES TRUST0.00%311,7561,8760.61%Dec 29, 2023
VANGUARD WELLINGTON FUND0.00%29,980--Feb 29, 2024
SPDR INDEX SHARES FUNDS0.00%12,789--Dec 31, 2023
Guggenheim Active Allocation Fund0.00%408--Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%7,385--Feb 29, 2024
NORTHERN FUNDS0.00%51,996-125,773-70.75%Dec 29, 2023
VICTORY PORTFOLIOS0.00%1,505--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%55--Dec 31, 2023
FLEXSHARES TRUST0.00%3,572--Jan 31, 2024
Janus Detroit Street Trust0.00%6,034--Jan 31, 2024
Brinker Capital Destinations Trust0.00%2,3532,353-Feb 29, 2024
Dimensional ETF Trust0.00%16,936--Jan 31, 2024
Brighthouse Funds Trust I0.00%391,6105,5401.43%Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%76,516-4,300-5.32%Dec 31, 2023
PACE SELECT ADVISORS TRUST0.00%10,899--Jan 31, 2024
AMERICAN BEACON FUNDS0.00%118,334--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%10,496-42-0.40%Jan 31, 2024
Meeder Funds0.00%122--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%2,519--Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%67,765--Dec 31, 2023
Fidelity Rutland Square Trust II0.00%18,697--Feb 29, 2024
Advisors' Inner Circle Fund III0.00%202--Jan 31, 2024
Brighthouse Funds Trust II0.00%28,658--Dec 31, 2023
iShares U.S. ETF Trust0.00%1,166--Jan 31, 2024
PACIFIC SELECT FUND0.00%33,964--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%17,930-24,267-57.51%Dec 31, 2023
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS0.00%13,949--Jan 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%1,808--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%5,834--Dec 31, 2023
Bridge Builder Trust0.00%26,636--Dec 31, 2023

Lexicon Pharmaceuticals's largest mutual fund holder by % of total assets is "Federated Hermes MDT Series", owning 1.69M shares, compromising 0.69% of its total assets.

Lexicon Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2465-39.25%
31 Dec, 23107-3.60%
30 Sep, 23111-10.48%
30 Jun, 2312420.39%
31 Mar, 23103-
31 Dec, 221037.29%
30 Sep, 229610.34%
30 Jun, 2287-13.86%
31 Mar, 22101-11.40%
31 Dec, 2111415.15%
30 Sep, 2199-11.61%
30 Jun, 211122.75%
31 Mar, 211090.93%
31 Dec, 2010817.39%
30 Sep, 2092-14.02%
30 Jun, 20107-4.46%
31 Mar, 20112-6.67%
31 Dec, 1912012.15%
30 Sep, 19107-6.96%
30 Jun, 19115-9.45%
31 Mar, 191270.79%
31 Dec, 18126-
30 Sep, 18126-1.56%
30 Jun, 181280.79%
31 Mar, 18127-3.05%
31 Dec, 17131-10.27%
30 Sep, 171463.55%
30 Jun, 17141-1.40%
31 Mar, 17143-4.03%
31 Dec, 161491.36%
30 Sep, 161473.52%
30 Jun, 161428.40%
31 Mar, 161316.50%
31 Dec, 1512317.14%
30 Sep, 1510523.53%
30 Jun, 1585-

As of 31 Mar 24, 65 institutions are holding Lexicon Pharmaceuticals's shares, representing a decrease of -39.25% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24153,343,347-15.93%
31 Dec, 23182,407,025-3.19%
30 Sep, 23188,425,746-1.34%
30 Jun, 23190,987,89731.23%
31 Mar, 23145,533,477-0.87%
31 Dec, 22146,811,759-1.32%
30 Sep, 22148,769,06625.35%
30 Jun, 22118,686,853-1.11%
31 Mar, 22120,021,967-1.14%
31 Dec, 21121,411,2310.37%
30 Sep, 21120,966,3242.83%
30 Jun, 21117,639,848-2.94%
31 Mar, 21121,202,374-0.59%
31 Dec, 20121,927,57316.95%
30 Sep, 20104,253,690-2.70%
30 Jun, 20107,141,9492.24%
31 Mar, 20104,799,519-2.15%
31 Dec, 19107,104,7784.60%
30 Sep, 19102,390,646-3.11%
30 Jun, 19105,678,7951.15%
31 Mar, 19104,476,802-0.74%
31 Dec, 18105,255,610-2.06%
30 Sep, 18107,472,461-1.20%
30 Jun, 18108,773,871-0.87%
31 Mar, 18109,729,174-1.42%
31 Dec, 17111,310,428-2.99%
30 Sep, 17114,738,0620.26%
30 Jun, 17114,439,2800.21%
31 Mar, 17114,194,6833.50%
31 Dec, 16110,329,061-0.02%
30 Sep, 16110,347,242-0.34%
30 Jun, 16110,728,727-0.02%
31 Mar, 16110,749,2921.34%
31 Dec, 15109,284,0913.32%
30 Sep, 15105,767,6789.27%
30 Jun, 1596,792,385-

Lexicon Pharmaceuticals (LXRX) has 153.34M shares outstanding as of 31 Mar 24, down -15.93% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2469.35%1.25%
31 Dec, 2374.47%0.88%
30 Sep, 2392.01%0.90%
30 Jun, 23101.04%1.70%
31 Mar, 2377.00%1.27%
31 Dec, 2277.79%1.08%
30 Sep, 2285.06%1.35%
30 Jun, 2279.33%1.23%
31 Mar, 2280.47%1.21%
31 Dec, 2181.54%1.18%
30 Sep, 2182.96%1.25%
30 Jun, 2181.44%1.14%
31 Mar, 2184.53%0.85%
31 Dec, 2099.65%1.06%
30 Sep, 2097.15%0.97%
30 Jun, 20100.06%1.03%
31 Mar, 2098.37%0.97%
31 Dec, 19100.78%1.09%
30 Sep, 1996.35%0.97%
30 Jun, 1999.44%1.02%
31 Mar, 1998.51%1.00%
31 Dec, 1899.37%0.96%
30 Sep, 18101.50%0.96%
30 Jun, 18102.76%0.95%
31 Mar, 18103.84%0.93%
31 Dec, 17105.77%0.90%
30 Sep, 17108.67%0.92%
30 Jun, 17108.68%0.91%
31 Mar, 17109.32%0.97%
31 Dec, 16106.03%0.94%
30 Sep, 16106.22%0.93%
30 Jun, 16106.64%0.93%
31 Mar, 16106.82%0.96%
31 Dec, 15105.46%1.01%
30 Sep, 15102.08%1.17%
30 Jun, 1593.42%-

As of 31 Mar 24, Lexicon Pharmaceuticals is held by 69.35% institutional shareholders, representing a 1.25% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2434-39.29%
31 Dec, 23563.70%
30 Sep, 2354-32.50%
30 Jun, 238056.86%
31 Mar, 2351-
31 Dec, 2251-13.56%
30 Sep, 225973.53%
30 Jun, 2234-20.93%
31 Mar, 2243-30.65%
31 Dec, 216258.97%
30 Sep, 2139-37.10%
30 Jun, 21626.90%
31 Mar, 21587.41%
31 Dec, 205445.95%
30 Sep, 2037-35.09%
30 Jun, 20571.79%
31 Mar, 2056-3.45%
31 Dec, 195848.72%
30 Sep, 1939-2.50%
30 Jun, 1940-28.57%
31 Mar, 195627.27%
31 Dec, 1844-
30 Sep, 1844-25.42%
30 Jun, 185915.69%
31 Mar, 1851-10.53%
31 Dec, 1757-13.64%
30 Sep, 17663.13%
30 Jun, 1764-9.86%
31 Mar, 1771-5.33%
31 Dec, 1675-7.41%
30 Sep, 16813.85%
30 Jun, 16786.85%
31 Mar, 167317.74%
31 Dec, 1562-6.06%
30 Sep, 1566-22.35%
30 Jun, 1585-

34 institutional shareholders have increased their position in LXRX stock as of 31 Mar 24 compared to 56 in the previous quarter (a -39.29% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2412-45.45%
31 Dec, 2322-24.14%
30 Sep, 232938.10%
30 Jun, 2321-36.36%
31 Mar, 233313.79%
31 Dec, 222945.00%
30 Sep, 2220-33.33%
30 Jun, 2230-16.67%
31 Mar, 223628.57%
31 Dec, 2128-20.00%
30 Sep, 213525.00%
30 Jun, 2128-3.45%
31 Mar, 2129-12.12%
31 Dec, 203326.92%
30 Sep, 20264.00%
30 Jun, 2025-10.71%
31 Mar, 2028-15.15%
31 Dec, 193313.79%
30 Sep, 1929-12.12%
30 Jun, 19336.45%
31 Mar, 1931-27.91%
31 Dec, 1843-
30 Sep, 184319.44%
30 Jun, 18365.88%
31 Mar, 1834-10.53%
31 Dec, 173818.75%
30 Sep, 1732-28.89%
30 Jun, 17457.14%
31 Mar, 174210.53%
31 Dec, 1638-9.52%
30 Sep, 164213.51%
30 Jun, 163719.35%
31 Mar, 1631-13.89%
31 Dec, 153671.43%
30 Sep, 1521-
30 Jun, 15--

12 institutional shareholders have reduced their position in LXRX stock as of 31 Mar 24 compared to 22 in the previous quarter (a -45.45% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2465-39.25%153,343,347-15.93%69.35%1.25%34-39.29%12-45.45%
31 Dec, 23107-3.60%182,407,025-3.19%74.47%0.88%563.70%22-24.14%
30 Sep, 23111-10.48%188,425,746-1.34%92.01%0.90%54-32.50%2938.10%
30 Jun, 2312420.39%190,987,89731.23%101.04%1.70%8056.86%21-36.36%
31 Mar, 23103-145,533,477-0.87%77.00%1.27%51-3313.79%
31 Dec, 221037.29%146,811,759-1.32%77.79%1.08%51-13.56%2945.00%
30 Sep, 229610.34%148,769,06625.35%85.06%1.35%5973.53%20-33.33%
30 Jun, 2287-13.86%118,686,853-1.11%79.33%1.23%34-20.93%30-16.67%
31 Mar, 22101-11.40%120,021,967-1.14%80.47%1.21%43-30.65%3628.57%
31 Dec, 2111415.15%121,411,2310.37%81.54%1.18%6258.97%28-20.00%
30 Sep, 2199-11.61%120,966,3242.83%82.96%1.25%39-37.10%3525.00%
30 Jun, 211122.75%117,639,848-2.94%81.44%1.14%626.90%28-3.45%
31 Mar, 211090.93%121,202,374-0.59%84.53%0.85%587.41%29-12.12%
31 Dec, 2010817.39%121,927,57316.95%99.65%1.06%5445.95%3326.92%
30 Sep, 2092-14.02%104,253,690-2.70%97.15%0.97%37-35.09%264.00%
30 Jun, 20107-4.46%107,141,9492.24%100.06%1.03%571.79%25-10.71%
31 Mar, 20112-6.67%104,799,519-2.15%98.37%0.97%56-3.45%28-15.15%
31 Dec, 1912012.15%107,104,7784.60%100.78%1.09%5848.72%3313.79%
30 Sep, 19107-6.96%102,390,646-3.11%96.35%0.97%39-2.50%29-12.12%
30 Jun, 19115-9.45%105,678,7951.15%99.44%1.02%40-28.57%336.45%
31 Mar, 191270.79%104,476,802-0.74%98.51%1.00%5627.27%31-27.91%
31 Dec, 18126-105,255,610-2.06%99.37%0.96%44-43-
30 Sep, 18126-1.56%107,472,461-1.20%101.50%0.96%44-25.42%4319.44%
30 Jun, 181280.79%108,773,871-0.87%102.76%0.95%5915.69%365.88%
31 Mar, 18127-3.05%109,729,174-1.42%103.84%0.93%51-10.53%34-10.53%
31 Dec, 17131-10.27%111,310,428-2.99%105.77%0.90%57-13.64%3818.75%
30 Sep, 171463.55%114,738,0620.26%108.67%0.92%663.13%32-28.89%
30 Jun, 17141-1.40%114,439,2800.21%108.68%0.91%64-9.86%457.14%
31 Mar, 17143-4.03%114,194,6833.50%109.32%0.97%71-5.33%4210.53%
31 Dec, 161491.36%110,329,061-0.02%106.03%0.94%75-7.41%38-9.52%
30 Sep, 161473.52%110,347,242-0.34%106.22%0.93%813.85%4213.51%
30 Jun, 161428.40%110,728,727-0.02%106.64%0.93%786.85%3719.35%
31 Mar, 161316.50%110,749,2921.34%106.82%0.96%7317.74%31-13.89%
31 Dec, 1512317.14%109,284,0913.32%105.46%1.01%62-6.06%3671.43%
30 Sep, 1510523.53%105,767,6789.27%102.08%1.17%66-22.35%21-
30 Jun, 1585-96,792,385-93.42%-85---

Lexicon Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 14, 2024Artal International S.C.A.director, 10 percent owner M-ExemptSell1,150,922---
Apr 29, 2024Swain Judith Ldirector-M-ExemptSell8,032---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 14, 2024Artal International S.C.A.director, 10 percent owner M-ExemptBuy57,546,100$0.01$575.46K136,180,481
May 14, 2024Artal International S.C.A.director, 10 percent owner A-AwardBuy1,150,922--1,150,922
May 14, 2024Artal International S.C.A.director, 10 percent owner M-ExemptSell1,150,922---
May 13, 2024Swain Judith Ldirector-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024Swain Judith Ldirector-A-AwardBuy36,810--36,810
May 13, 2024Sullivan Diane E.director-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024Sullivan Diane E.director-A-AwardBuy36,810--36,810
May 13, 2024SOBECKI CHRISTOPHER Jdirector-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024SOBECKI CHRISTOPHER Jdirector-A-AwardBuy36,810--36,810
May 13, 2024LEFKOWITZ ROBERT J MDdirector-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024LEFKOWITZ ROBERT J MDdirector-A-AwardBuy36,810--36,810
May 13, 2024DEBBANE RAYMONDdirector-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024DEBBANE RAYMONDdirector-A-AwardBuy36,810--36,810
May 13, 2024BARKER SAM Ldirector-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024BARKER SAM Ldirector-A-AwardBuy36,810--36,810
May 13, 2024Amouyal Philippedirector-A-AwardBuy44,906$1.79$80.38K44,906
May 13, 2024Amouyal Philippedirector-A-AwardBuy36,810--36,810
Apr 29, 2024Swain Judith Ldirector-M-ExemptBuy8,032--48,364
Apr 29, 2024Swain Judith Ldirector-M-ExemptSell8,032---
Apr 29, 2024SOBECKI CHRISTOPHER Jdirector-M-ExemptBuy8,032--167,055

The last insider sell of Lexicon Pharmaceuticals's stock was made by Artal International S.C.A. on May 14 2024, selling 1,150,922 shares at - per share (valued at -).

Lexicon Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024227314.29%
Q1 20244130136.67%
Q4 20236--
Q3 20233--
Q2 2023328400.00%
Q1 20234132128.13%
Q3 20229--
Q2 2022187257.14%
Q1 20224027148.15%
Q4 2021-19-
Q3 20211714.29%
Q2 2021248300.00%
Q1 20213727137.04%
Q4 202022100.00%
Q2 20203115206.67%
Q1 20204738123.68%
Q4 2019-13-
Q3 2019124--
Q2 201916--
Q1 20193931125.81%

22 total buy trades, and 7 total sell trades (buy/sell ratio of 3.14%) were made by Lexicon Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q4 20235--
Q3 20232--
Q2 20238--
Q1 2023---
Q3 20229--
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021-2-
Q4 20202--
Q2 2020---
Q1 2020---
Q4 2019---
Q3 2019124--
Q2 2019---
Q1 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lexicon Pharmaceuticals's stocks.

Lexicon Pharmaceuticals Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
CWBRCohBar, Inc.
GRTXGalera Therapeutics, Inc.
MREOMereo BioPharma Group plc
ELEVElevation Oncology, Inc.
XFORX4 Pharmaceuticals, Inc.
BLRXBioLineRx Ltd.
DAWNDay One Biopharmaceuticals, Inc.
MCRBSeres Therapeutics, Inc.
ARDXArdelyx, Inc.
OCEAOcean Biomedical, Inc.
EFTReFFECTOR Therapeutics, Inc.
IBRXImmunityBio, Inc.
ENVBEnveric Biosciences, Inc.
AVROAVROBIO, Inc.
HOOKHOOKIPA Pharma Inc.
HEPAHepion Pharmaceuticals, Inc.

LXRX Ownership FAQ


Lexicon Pharmaceuticals is owned by institutional shareholders (69.35%), insiders (1.15%), and public (29.51%). The largest institutional shareholder of Lexicon Pharmaceuticals is ARTAL GROUP S.A. (53.16% of total shares) and the top mutual fund owner is Federated Hermes MDT Series (0.69% of total shares).

Lexicon Pharmaceuticals's major institutional shareholders are ARTAL GROUP S.A., FMR LLC, BLACKROCK INC., VANGUARD GROUP INC, and ORBIMED ADVISORS LLC. The top five shareholders own together 67.42% of the company's share outstanding.

As of Mar 2024, there are 65 institutional shareholders of Lexicon Pharmaceuticals.

ARTAL GROUP S.A owns 117.55M shares of Lexicon Pharmaceuticals, representing 53.16% of the company's total shares outstanding, valued at $282.13M (as of Mar 2024).

As of Mar 2024, FMR LLC holds 13.89M shares of Lexicon Pharmaceuticals (LXRX), compromising 6.28% of the company, valued at $33.35M.

BLACKROCK INC is the third largest holder of Lexicon Pharmaceuticals. The company owns 7.69M of the company's shares outstanding (worth $18.46M).